Flex Ltd. logo FLEX - Flex Ltd.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $145.17 DETAILS
HIGH: $180.00
LOW: $80.00
MEDIAN: $169.50
CONSENSUS: $145.17
UPSIDE: 9.59%

Stock News

Flex to Participate in Upcoming Investor Conferences

Flex to Participate in Upcoming Investor Conferences

AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- Flex (NASDAQ: FLEX) has announced that members of its leadership team will participate in the following upcoming investor conferences: KeyBanc Industrials and Basic Materials Conference Date: Wednesday, May 27, 2026Meetings only; no formal presentation or webcast Bank of America Global Technology Conference Date: Tuesday, June 2, 2026Presentation time: 5:20 p.m. CT / 6:20 p.m.

May 22, 2026 12:05 PM prnewswire.com
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

SAN DIEGO & EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new system will be available in Germany soon. Dexcom Flex is made for people using basal insulin, oral medications or GLP-1 receptor agonists, expanding access to CGM technology for a broader Type 2 diabetes population. D.

May 18, 2026 03:31 AM businesswire.com

Price Targets